mirvetuximab soravtansine and pembrolizumab combo shows promise in endometrial cancer subtype
Published 7 months ago • 73 plays • Length 3:38Download video MP4
Download video MP3
Similar videos
-
0:59
dr secord on mirvetuximab soravtansine in platinum-sensitive, frα-high ovarian cancer
-
0:45
results for combination bevacizumab plus mirvetuximab soravtansine in ovarian cancer
-
1:27
dr. gilbert on evaluating mirvetuximab soravtansine in platinum-agnostic ovarian cancer
-
1:59
dr. english on mirvetuximab soravtansine in ovarian cancer
-
2:15
dr. moore on early-phase data with mirvetuximab soravtansine in ovarian cancer
-
1:50
an overview of a study exploring mirvetuximab soravtansine in ovarian cancer
-
5:03
forward i: mirvetuximab soravtansine vs chemo in platinum-resistant ovarian cancer
-
2:16
dr. matulonis discusses mirvetuximab soravtansine plus pembrolizumab in ovarian cancer
-
1:49
dr. moore on safety profile of mirvetuximab soravtansine in ovarian cancer
-
1:59
dr. gilbert on the safety profile of mirvetuximab soravtansine/bevacizumab in ovarian cancer
-
0:26
copy of dr. english on mirvetuximab soravtansine in ovarian cancer
-
0:56
mirvetuximab soravtansine with pembrolizumab in mss endometrial cancer
-
5:08
what emerging myeloma treatments are showing promise?
-
3:15
pembrolizumab demonstrates promise in patients with pretreated metastatic gastric cancer
-
2:05
cancer in pregnancy 15 years after - h. a. azim
-
4:02
inspired by mert who overcame endometrial cancer
-
2:14
cancer in pregnancy 15 years after - p. berveiller